Aptar Pharma provides drug delivery systems, components and services globally. Products include: nasal spray pumps, MDI valves, dose indicators & counters, DPIs, electronic / connected devices, eye-droppers, elastomeric components (for injectable delivery devices), and a two-step autoinjector.
Aptar Pharma is one of the drug delivery device industry’s major companies, providing drug delivery systems, components and services to pharmaceutical, biotech and consumer healthcare customers worldwide, across the nasal, pulmonary, ophthalmic, dermal and injectable routes of administration.
Products include: nasal spray pumps, MDI valves, dose indicators and counters, DPIs, electronic devices, connected devices, eye-droppers, elastomeric components (for parenteral primary packaging / injectable delivery devices), a two-step autoinjector exclusively licensed to BD, and more.
Overall, six billion components and systems are produced annually across 12 manufacturing sites and are accessed by 1.6 billion patients, and over US$50 billion worth of pharmaceutical products use Aptar Pharma’s systems.
The company’s services include: customised development, laboratory services, regulatory and technical support, and elastomer development.
Aptar Pharma is part of AptarGroup, Inc (NYSE:ATR).